SYNERGY PHARMACEUTICALS INC DEL Common Stock

YTD

ALL

Why Robinhood?

You can watch SGYPQ and buy or sell other stocks, ETFs, and their options commission-free!

About SGYPQ

Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation.

CEO

Gary S. Jacob, PhD

CEOGary S. Jacob, PhD

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1992

Founded1992

Employees

—

Employees—

SGYPQ Key Statistics

Market cap

1.59M

Market cap1.59M

Price-Earnings ratio

-0.01

Price-Earnings ratio-0.01

Dividend yield

—

Dividend yield—

Average volume

1.60M

Average volume1.60M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$2.10

52 Week high$2.10

52 Week low

$0.005

52 Week low$0.005